Product Introduction:
ADGLIM MP 1MG TABLET is likely a combination medication containing Glimepiride (1mg), Metformin (500mg), and Pioglitazone (15mg). This combination is often prescribed for individuals with type 2 diabetes to address multiple aspects of glucose regulation. Glimepiride stimulates insulin release, Metformin improves insulin sensitivity and reduces glucose production, while Pioglitazone enhances insulin action in peripheral tissues.
ADGLIM MP 1MG TABLET should be taken in the dose and duration as advised by your doctor. It must be taken with food to avoid stomach upset. If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose. Overdose may lead to low blood sugar (hypoglycemia).
Some people may develop hypoglycemia (low blood sugar level) when this medicine is taken along with other antidiabetic medicines, alcohol or upon skipping a meal. Monitor your blood sugar levels regularly while taking it. Other common side effects of this medicine include nausea, diarrhea, stomach pain, headache, bone fracture, and respiratory tract infection.
Before taking this medicine, inform your doctor if you have any kidney, liver or heart problems. Pregnant or breastfeeding women should also consult their doctor before taking it. Your doctor will check your kidney function tests before starting treatment with it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects.
Benefits:
- Comprehensive Glycemic Control: The combination aims to provide a comprehensive approach to managing blood sugar levels in individuals with type 2 diabetes.
- Insulin Sensitivity: Metformin and Pioglitazone work to improve insulin sensitivity, reducing insulin resistance.
- Pancreatic Insulin Release: Glimepiride stimulates the pancreas to release insulin, aiding in lowering blood sugar levels.
Side Effects:
Common side effects may include:
- Gastrointestinal issues (nausea, diarrhea)
- Hypoglycemia (low blood sugar), especially with Glimepiride
- Weight gain (common with Pioglitazone)
- Edema (fluid retention, common with Pioglitazone)
It’s important to report any unusual or severe side effects to your healthcare provider.
Usage Guidelines:
Dosage guidelines should be followed as prescribed by your healthcare provider. Typically, these tablets are taken with meals to maximize their effectiveness and minimize side effects. Dosage adjustments may be made based on individual health conditions and needs.
Drug Interactions:
Inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions. This combination may interact with other medications, affecting their efficacy or increasing the risk of side effects. Interactions may occur with certain medications, including those affecting liver function.
Always consult with your healthcare professional for personalized advice. They can provide specific guidance based on your health status and any potential interactions with other medications you may be taking.
SAFETY ADVICE
Alcohol
Pregnancy
Breast feeding
Driving
Kidney
Use of ADGLIM MP 1MG TABLET is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
Use of ADGLIM MP 1MG TABLET is not recommended in patients with severe liver disease.
| Weight | 0.5 kg |
|---|---|
| Dimensions | 10 × 10 × 10 cm |
